Jenny Barnett, PhD
CEO, Monument Tx
Jenny was Chief Scientific Officer at Cambridge Cognition where she led clinical trial, healthcare and R&D functions before spinning out Monument Therapeutics. She has an MA in Experimental Psychology from Oxford University, a PhD in the Epidemiology of Schizophrenia from the University of Cambridge, and completed post-doctoral work at Massachusetts General Hospital and the Broad Institute of Harvard and MIT. She is the author of more than 70 papers, six patents, and two popular science books and is an honorary member of the University of Cambridge Department of Psychiatry.